De novo donor-specific human leukocyte antigen antibodies in nonsensitized kidney transplant recipients after T cell-mediated rejection

Transplantation

Volumn 99, Issue 5, 2015, Pages 965-972

  Chemouny, Jonathan Maurice ^a,b   Suberbielle, Caroline ^c   Rabant, Marion ^d   Zuber, Julien ^b,d,e   Alyanakian, Marie Alexandra ^d   Lebreton, Xavier ^d,e   Carmagnat, Maryvonnick ^c   Pinheiro, Nathan ^d   Loupy, Alexandre ^b,d,e   Van Huyen, Jean Paul ^d   Timsit, Marc Olivier ^b,f   Charron, Dominique ^c   Legendre, Christophe ^b,d,e   Anglicheau, Dany ^b,d,e,g  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Labex Transplantex   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g INSTITUT NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CREATININE; HLA ANTIGEN; STEROID; ALLOANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE MEDIATED REJECTION; AGED; BIOPSY; BLOOD; DONOR; IMMUNOLOGY; KIDNEY; MIDDLE AGED; PATHOLOGY; T LYMPHOCYTE;

ADULT; AGED; BIOPSY; CREATININE; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TISSUE DONORS;

EID: 84930338524     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000448     Document Type: Article

References (24)

1. Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol. 2012;8:348.
2. Morath C, Opelz G, Zeier M, et al. Kidney transplantation for high-risk sensitized patients-the "Heidelberg algorithm". Transplant Proc 2011;43:801.
3. Tait BD, Susal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013;95:19.
4. Banasik M, Boratynska M, Koscielska-Kasprzak K, et al. The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome. Transplant Proc 2013;45:1449.
5. Everly MJ, Everly JJ, Arend LJ, et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009;9:1063.
6. Chaudhuri A, Ozawa M, Everly MJ, et al. The clinical impact of humoral immunity in pediatric renal transplantation. J Am Soc Nephrol 2013;24:655.
7. Gill JS, Landsberg D, Johnston O, et al. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation 2010; 89:178.
8. Everly MJ, Rebellato LM, Haisch CE, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation 2013;95:410.
9. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16:2804.
10. Liefeldt L, Brakemeier S, Glander P, et al. Donor-specific HLA antibodies in a cohort comparing everolimus with cyclosporine after kidney transplantation. Am J Transplant 2012;12:1192.
11. Moreso F, Carrera M, Goma M, et al. Early subclinical rejection as a risk factor for late chronic humoral rejection. Transplantation 2012;93:41.
12. Sanchez-Fructuoso AI, Santiago JL, Perez-Flores I, et al. De novo anti-HLA antibodies in renal allograft recipients: a cross-section study. Transplant Proc 2010;42:2874.
13. Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012;12:1157.
14. El Ters M, Grande JP, Keddis MT, et al. Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant 2013; 13:2334.
15. Wiebe C, Nickerson P. Posttransplant monitoring of de-novo human leukocyte antigen donor-specific antibodies in kidney transplantation. Curr Opin Organ Transplant 2013;18:470.
16. Delgado JC, Fuller A, Ozawa M, et al. No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study. Transplantation 2009;87:546.
17. DeVos JM, Gaber AO, Knight RJ, et al. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int 2012;82:598.
18. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010;10:464.
19. Gibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopath-ological correlates. Am J Transplant 2008;8:819.
20. Cooper JE, Gralla J, Cagle L, et al. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes. Transplantation 2011;91:1103.
21. Bachelet T, Couzi L, Guidicelli G, et al. Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection. Am J Transplant 2011;11:1543.
22. Jolly EC, Key T, Rasheed H, et al. Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation. Am J Transplant 2012;12:2845.
23. Aubert O, Bories MC, Suberbielle C, et al. Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies. Am J Transplant 2014;14:1439.
24. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014;14:272.